Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Genentech
Scientific Title
A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of BTRC4017A Administered Intravenously in Patients With Locally Advanced or Metastatic HER2-Expressing Cancers